Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term endothelial-cells. Found 11 abstracts

Rossi E, Fassan M, Aieta M, Zilio F, Celadin R, Borin M, Grassi A, Troiani L, Basso U, Barile C, Sava T, Lanza C, Miatello L, Jirillo A, Rugge M, Indraccolo S, Cristofanilli M, Amadori A, Zamarchi R. Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to Sunitinib in metastatic renal cancer. British Journal of Cancer. 2012 Oct;107(8):1286-94.
Rossi E, Fassan M, Aieta M, Zilio F, Celadin R, Borin M, Grassi A, Troiani L, Basso U, Barile C, Sava T, Lanza C, Miatello L, Jirillo A, Rugge M, Indraccolo S, Cristofanilli M, Amadori A, Zamarchi R. Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to Sunitinib in metastatic renal cancer. British Journal of Cancer. 2012 Oct;107(8):1286-94.   PMCID: PMC3494437
Burger RA. Overview of anti-angiogenic agents in development for ovarian cancer. Gynecologic Oncology. 2011 Apr;121(1):230-8.   PMCID: not NIH funded
Sasaroli D, Gimotty PA, Pathak HB, Hammond R, Kougioumtzidou E, Katsaros D, Buckanovich R, Devarajan K, Sandaltzopoulos R, Godwin AK, Scholler N, Coukos G, Stellani P VP. Novel surface targets and serum biomarkers from the ovarian cancer vasculature. Cancer Biology & Therapy. 2011 Aug;12(3):169-80.   PMCID: PMC3230481
Golovine K, Makhov P, Uzzo RG, Kutikov A, Kaplan DJ, Fox E, Kolenko VM. Cadmium down-regulates expression of XIAP at the post-transcriptional level in prostate cancer cells through an NF-kappa B-independent, proteasome-mediated mechanism - art. no. 183. Molecular Cancer. 2010 Jul;9:183.   PMCID: PMC3044330
Beacham DA, Cukierman E. Stromagenesis: The changing face of fibroblastic microenvironments during tumor progression. Seminars in Cancer Biology. 2005 Oct;15(5):329-41.
Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, Zhu ZP, Hicklin D, Wu Y, Port JL, Altorki N, Port ER, Ruggero D, Shmelkov SV, Jensen KK, Rafii S, Lyden D. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005 Dec 08;438(7069):820-7.
von Mehren M. Targeted therapy with imatinib: Hits and misses?. Journal of Clinical Oncology. 2005 Jan;23(1):8-10.
Wilm B, Ipenberg A, Hastie ND, Burch JB, Bader DM. The serosal mesothelium is a major source of smooth muscle cells of the gut vasculature. Development. 2005 Dec;132(23):5317-28.
Mabuchi S, Ohmichi M, Nishio Y, Hayasaka T, Kimura A, Ohta T, Kawagoe J, Takahashi K, Yada-Hashimoto N, Seino-Noda H, Sakata M, Motoyama T, Kurachi H, Testa JR, Tasaka K, Murata Y. Inhibition of inhibitor of nuclear factor-kappa B phosphorylation increase the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Clinical Cancer Research. 2004 Nov 15;10(22):7645-54.
Schultheiss TE, Stephens LC. Permanent Radiation Myelopathy. British Journal of Radiology. 1992 Sep;65(777):737-53.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term endothelial-cells

endothelial-cells expression carcinoma breast-cancer circulating tumour cells (CTC) renal cancer-circulating endothelial cells (CEC)-M30-sunitinib progression-free healthy-subjects lung-cancer tumor-necrosis-factor peripheral-blood therapy survival ep-cam Tyrosine kinase tumor progression stromagenesis-extracellular matrix-microenvironment-3D culture systems-stromal mechanosensors tyrosine kinase inhibitor tyrosine kinase phase-ii trial rat spinal-cord cell c-kit growth-factor receptor-1 epithelial-cells activation cell lung-cancer clinical-response apoptosis-protein therapeutic target blood-vessel development mouse model white matter chick-embryos ovarian Anti-angiogenic therapy chemotherapeutic-agents x-rays in-vitro angiogenesis prostate-cancer growth subepicardial mesenchyme l-selectin gene-expression diagnostics mesenchymal transformation x-linked inhibitor accelerated vessels platinum-resistant iap gut blood vessel development-mesothelia triple angiokinase inhibitor pancreatic-cancer chronic myeloid-leukemia radiation myelopathy clinical-trial Bevacizumab forkhead transcription factor growth epicardium chemokine receptors integrins contribute epithelial ovarian imatinib mesylate radiation response wilms-tumor gene cancer stromal cells focal adhesion kinase bevacizumab gynecologic-oncology-group coronary-arteries avian embryos profiling 3-dimensional extracellular-matrix zinc markers taxol-induced apoptosis radiotherapy biomarkers pathogenesis cell-survival stem-cells tumor angiogenesis regulated protein-kinase enteric nervous-system central-nervous-system inhibitors tumor adhesion wild-type metastasis reactive stromal fibroblasts fibroblast-growth-factor Ovarian cancer akt gastrointestinal stromal tumors multiple-sclerosis cancer metastasis activation protein x-linked-inhibitor hepatocellular-carcinoma cytosine-arabinoside vascular radiation serum tgf-beta collagen-matrix
Last updated on Friday, January 03, 2020